Mission

The mission of the MCA’s Clinical Trials Consortium is to cultivate, expand, and accelerate our region’s infrastructure and competitiveness in research and innovation.

Vision

To be a significant contributor to the global healthcare community, by helping to advance the commercialization of novel diagnostics and medical breakthroughs that help individuals live longer, healthier, more active lives.

Overview

The Clinical Trials Consortium is a forum that facilitates dialogue among stakeholders. It organizes, plans, and implements strategies and initiatives designed to grow the region’s clinical research community, give access increased access to cutting edge medicine, engage local physicians in research, and provide high quality job opportunities. In doing this successfully, the consortium will also help to advance the commercialization of novel diagnostics and medical breakthroughs that help people live longer, healthier and more active lives.

Objectives

1. Catalog the industry in each of the three regional communities (El Paso, Texas; Northern Chihuahua, Southern New Mexico) to establish an industry baseline and use for strategic analysis. Track changes over time.
2. Identify weaknesses or areas of enhancement in the regional ecosystem that could be preventing or limiting the future growth of the industry and region.
3. Create a strategic plan for improving the regional clinical research and health care industries that is updated annually in response to progress made as well as new disruptions, threats and opportunities. Through this strategic plan identify core set of initiatives designed to create impactful change benefiting the stakeholders across the ecosystem.
4. Implement strategic initiatives.
5. Execute or partner with other stakeholders to execute a strategy for growth and innovation.
6. Excite and motivate the clinical research and healthcare industry to grow and improve -inspire, foster, influence.
7. Measure the impact of the strategic initiatives on key performance metrics.
8. Disseminate what is learned.

Composition

The Clinical Trials Consortium is comprised of more than thirty key industry stakeholders from the El Paso, Texas; Juarez, Mexico, and southern New Mexico region. Members include hospital and health systems, physicians, clinical research coordinators, integrated research organizations, diagnostic service providers, academic faculty and others. As the Executive Sponsor, the Medical Center of the Americas Foundation serves as a convener and neutral facilitator for the Clinical Trials Consortium.